<DOC>
	<DOCNO>NCT00677599</DOCNO>
	<brief_summary>The purpose placebo control trial determine whether year long intervention flavonoid ( find cocoa soy ) effective reduce risk cardiovascular disease postmenopausal woman type 2 diabetes , standard therapy ( statin ) . A range marker cardiovascular disease risk study volunteer also provide urine blood sample . 152 postmenopausal woman , locality , recruit study .</brief_summary>
	<brief_title>The FLAVO Trial : Dietary Flavonoids Cardiovascular Disease Risk Reduction Postmenopausal Women With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Inclusion Criteria Female Having natural menopause minimum 1 year since last menstruation Caucasian 70 year Type 2 diabetic Those use statin ( ≥40 mg simvastatin ≥10 mg atorvastatin ) least 12 month Not currently take Hormone Replacement Therapy ( HRT ) take HRT minimum 6 month prior commencement Having significant past present medical history vascular disease , cancer ( specifically breast , uterine ovarian ) Neversmokers , exsmokers give smoke least 12 month recruitment study Exclusion Criteria Currently take HRT take medication within 6 month trial Those prescribe use statin therapy le 12 month Significant past present medical history vascular disease ( include ECG enzyme confirm myocardial infarction , clinical angina , ischaemic stroke peripheral vascular disease , intermittent claudication ) cancer ( especially breast , uterine ovarian ) Hypertensive 's systolic BP ≥ 160 mm Hg maximum , hypertensive 's systolic BP ≤160 mm Hg maximum , receive antihypertensive therapy le 12 month increase medication indicate poor control Current smoker give smoke less 12 month recruitment study Those prescribed aspirin period le 12 month prior recruitment Those prescribed insulin period le 12 month prior recruitment increase medication indicate poor control Regular nonprescribed use antiinflammatory pain relief medication ( i.e . aspirin , paracetamol , cocodamol ) . Taking counter indicative medication e.g . steroidal medication trial , within 1 month trial beginning . Taking food / dietary supplement e.g . vitamin , mineral , fish oil , plant oil , isoflavones , soy product , carotenoid trial ( unless prepare cease intake , 1 month precede trial ) . Having vaccination ( exclude flu vaccination ) antibiotic within 3 month start trial , vaccination schedule trial Parallel participation another research project involve dietary intervention and/or sample biological fluids/material Assessed clinical screening : HbA1c ≥ 10 % ; Creatinine &gt; 125µmol/L ; ALP &gt; 378 IU/L ; ALT &gt; 150 IU/L ; GGT &gt; 180 IU/L</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Cardiovascular disease</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>flavonoid</keyword>
	<keyword>cocoa</keyword>
	<keyword>soy</keyword>
	<keyword>epicatechin</keyword>
	<keyword>postmenopausal</keyword>
	<keyword>carotid intima medium thickness</keyword>
	<keyword>plaque volume</keyword>
</DOC>